Publication | Closed Access

Biodegradation of graphene-based nanomaterials in blood plasma affects their biocompatibility, drug delivery, targeted organs and antitumor ability

Graphene NanomeshesNanomedicineGraphene Quantum DotEngineeringCarbon-based MaterialNanomaterialsGraphene FiberGrapheneDrug Delivery SystemsBiomedical EngineeringBiomaterialsGraphene-based NanomaterialsBlood Plasma